ASTEC

Astec LifeSciences Limited

Specialty and commodity chemicals in pesticides and agrochemicals

Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals

godrejastec.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹710.45
Market cap
1,583 Cr
Stock P/E
Loss (TTM EPS ₹-30.27)
P/B
4.05
Dividend yield
0.2%
ROE (FY26)
-20.7%
ROCE (FY26)
-5.5%
Operating margin (FY26)
-11.0%
Debt / equity (FY26)
1.15

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Astec (Astec LifeSciences) makes agrochemical active ingredients (technical), bulk products, formulations and intermediates for local and global customers, selling through an Enterprise business and a contract development and manufacturing (CDMO) business.

Company snapshot

13thBy market cap

Ranked among 23 companies in Pesticides & Agrochemicals.

What we see

Concerns
  • ✗Net margin is negative — the company is spending more than it earns right now.
2 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales111 Cr51 Cr154 Cr69 Cr99 Cr94 Cr120 Cr91 Cr74 Cr125 Cr159 Cr84 Cr
Operating expenses (approx.)114 Cr69 Cr141 Cr116 Cr118 Cr100 Cr114 Cr102 Cr80 Cr121 Cr149 Cr84 Cr
EBITDA-3 Cr-18 Cr13 Cr-46 Cr-20 Cr-6 Cr6 Cr-11 Cr-7 Cr4 Cr9 Cr-0.67 Cr
OPM %-3.1%-36.1%8.3%-66.7%-20.0%-6.1%4.6%-12.1%-9.1%3.2%5.8%-0.8%
Other income0.98 Cr0.91 Cr2 Cr0.92 Cr2 Cr2 Cr0.79 Cr0.51 Cr1 Cr0.82 Cr3 Cr0.73 Cr
Interest6 Cr6 Cr7 Cr7 Cr9 Cr10 Cr10 Cr11 Cr8 Cr7 Cr8 Cr8 Cr
Depreciation9 Cr9 Cr9 Cr9 Cr11 Cr11 Cr12 Cr11 Cr10 Cr11 Cr12 Cr11 Cr
Profit before tax-18 Cr-32 Cr-0.93 Cr-62 Cr-39 Cr-25 Cr-16 Cr-33 Cr-24 Cr-16 Cr-8 Cr-19 Cr
Tax %23.8%24.5%-4.1%35.6%-0.0%-60.5%-2.7%-0.0%-0.0%-0.1%1.9%0.2%
Net profit-13 Cr-24 Cr-0.96 Cr-40 Cr-39 Cr-40 Cr-16 Cr-33 Cr-24 Cr-16 Cr-8 Cr-19 Cr
EPS (₹)₹-6.85₹-12.41₹-0.50₹-20.26₹-19.66₹-20.59₹-8.20₹-16.85₹-11.35₹-7.04₹-3.48₹-8.40

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales313 Cr371 Cr431 Cr523 Cr555 Cr677 Cr628 Cr458 Cr381 Cr448 CrSign in free for the trailing twelve months
Operating expenses (approx.)251 Cr302 Cr354 Cr437 Cr443 Cr522 Cr552 Cr464 Cr448 Cr453 CrSign in free for the trailing twelve months
EBITDA62 Cr69 Cr76 Cr85 Cr112 Cr154 Cr76 Cr-6 Cr-66 Cr-5 CrSign in free for the trailing twelve months
OPM %19.9%18.6%17.7%16.3%20.1%22.8%12.1%-1.3%-17.4%-1.0%Sign in free for the trailing twelve months
Other income3 Cr8 Cr11 Cr12 Cr8 Cr10 Cr13 Cr6 Cr6 Cr5 CrSign in free for the trailing twelve months
Interest12 Cr11 Cr12 Cr13 Cr5 Cr9 Cr21 Cr25 Cr37 Cr35 CrSign in free for the trailing twelve months
Depreciation14 Cr15 Cr19 Cr23 Cr26 Cr34 Cr34 Cr36 Cr44 Cr45 CrSign in free for the trailing twelve months
Profit before tax29 Cr56 Cr56 Cr61 Cr89 Cr121 Cr35 Cr-62 Cr-141 Cr-81 CrSign in free for the trailing twelve months
Tax %33.3%37.1%36.0%22.5%26.9%25.8%26.8%24.1%4.5%0.2%Sign in free for the trailing twelve months
Net profit19 Cr35 Cr36 Cr48 Cr65 Cr90 Cr26 Cr-47 Cr-135 Cr-81 CrSign in free for the trailing twelve months
EPS (₹)₹9.81₹17.88₹18.28₹24.29₹33.23₹45.87₹13.04₹-23.93₹-68.71₹-37.79Sign in free for the trailing twelve months
Dividend payout %————4.5%3.3%11.5%———Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital20 Cr20 Cr20 Cr20 Cr20 Cr20 Cr20 Cr20 Cr20 Cr22 Cr
Reserves119 Cr150 Cr183 Cr227 Cr290 Cr377 Cr400 Cr350 Cr215 Cr368 Cr
Borrowings126 Cr124 Cr176 Cr99 Cr187 Cr279 Cr341 Cr494 Cr555 Cr449 Cr
Other liabilities69 Cr119 Cr83 Cr226 Cr181 Cr221 Cr219 Cr112 Cr92 Cr102 Cr
Total liabilities334 Cr413 Cr461 Cr572 Cr678 Cr897 Cr979 Cr975 Cr881 Cr942 Cr
Fixed assets (net)99 Cr112 Cr165 Cr192 Cr212 Cr338 Cr287 Cr353 Cr497 Cr424 Cr
CWIP8 Cr42 Cr19 Cr22 Cr112 Cr14 Cr112 Cr148 Cr0.13 Cr0.20 Cr
Investments0.0053 Cr0.0053 Cr0.0053 Cr0.0053 Cr0.0053 Cr0.0053 Cr30 Cr30 Cr0.0053 Cr30 Cr
Loans & advances——0.05 Cr29 Cr0.08 Cr0.15 Cr0.02 Cr0.04 Cr3 Cr3 Cr
Inventories66 Cr78 Cr93 Cr121 Cr106 Cr187 Cr295 Cr196 Cr160 Cr138 Cr
Trade receivables111 Cr123 Cr122 Cr161 Cr187 Cr274 Cr155 Cr169 Cr147 Cr248 Cr
Cash & bank3 Cr0.33 Cr0.21 Cr0.31 Cr0.34 Cr0.55 Cr0.47 Cr0.47 Cr0.58 Cr10 Cr
Other assets48 Cr57 Cr63 Cr46 Cr61 Cr84 Cr100 Cr78 Cr74 Cr90 Cr
Total assets334 Cr413 Cr461 Cr572 Cr678 Cr897 Cr979 Cr975 Cr881 Cr942 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity19 Cr65 Cr15 Cr168 Cr-8 Cr24 Cr75 Cr10 Cr-8 Cr-81 Cr
Cash from investing-18 Cr-49 Cr-52 Cr-74 Cr-73 Cr-104 Cr-113 Cr-135 Cr-15 Cr-4 Cr
Cash from financing-0.94 Cr-18 Cr37 Cr-95 Cr81 Cr80 Cr38 Cr125 Cr24 Cr94 Cr
Net cash flow0.60 Cr-3 Cr-0.12 Cr0.10 Cr0.03 Cr0.22 Cr-0.08 Cr-0.0019 Cr0.10 Cr9 Cr
Free cash flow (OCF − Capex)-2 Cr15 Cr-37 Cr123 Cr-111 Cr-80 Cr-43 Cr-125 Cr-30 Cr-86 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %15.5%22.5%18.0%21.4%18.9%19.3%7.3%-4.2%-13.2%-5.5%
ROE %13.8%20.6%17.6%19.2%21.0%22.7%6.1%-12.7%-57.3%-20.7%
Debtor days12912110311212314790135141201
Inventory days133127115133112153233224234186
Days payable11616278222132155140102119118
Cash conversion cycle1468613923103145183257255269
OCF / EBITDA %30.8%94.0%20.0%197.8%-7.3%15.3%97.9%———
OCF / EBITDA % (3 years)——47.8%107.8%64.2%52.4%26.3%48.3%n.m.—
Debt / equity0.920.730.870.400.600.700.811.342.361.15
Current ratio1.020.971.011.051.031.050.951.000.930.89
Net debt / EBITDA1.98—2.291.161.671.814.47———